Member Info for Toukankahmoon

You would hope so given that we are well below the recent offer price.

Icecool

I hope your team wins and that it is a great match

My “argument “ has never been that Avacta wouldn’t be very successful, more a matter of when? We now have a timeline I have faith in.

Yes I have been concerned about what has been happening this year but the most excellent presentation has made that clear to me and so I am excited again about the long term success of Avacta and its impact on people who are suffering.

I now await the abusive posts and the ‘you said’, ‘he said’, ‘she said’ but I can’t make my position any clearer than that.

Nanomat

Nice analysis if not a bit wordy.

I also find it sickening when certain rampers continually exaggerate the short term value of Avacta by posting ludicrous unfounded predictions of what they are sure will happen next week and very seldom does.

Buen

Video worth waiting for. Pipeline potential is mind blowing as is AVA6000 use in breast cancer in the interim. I now understand why arm2 results not of great significance (reduced to 2 patients by the end). Also understand issues so far in that doxorubicin not very effective against STS (1 min 20secs in). So P2 timeline has increased (breast cancer trials take longer and are more costly) but the rewards will be huge. However I think that you will have plenty more opportunities to buy shares at the current SP or thereabouts.

In conclusion this video is most thorough yet in explaining what is happening and where we are going A bright future indeed.

Ben

Why does saying I think it was GSA buying to close some of their short make me a troll?

Surely we want them to close their short?

GSA closing some of their short I would think.

Lot of editing and sound dubbing and CGI I heard. Also they are all to busy negotiating TO deals.

Closing a short I would have thought now the SP is low editor them.

Your award is in the post.

Well if it helps for you to just see positive things about our favourite company then go for it😄

Icecool

I feel the same way about your style of posts.

Anyway unless we reverse into a company that is already listed on NASDAQ, I don’t think we meet the requirements. Still I am saving a pot for the IPO to try to limit dilution.

“and the full rebrand suggests we will likely be looking at Nasdaq sooner rather than later as well.”

Really?

Ice

Now you’ve really made me proud. You put me in the group of people who because they don’t agree with your views are therefore not invested.

Icecool

So you’ve never included me under the Amigos category

Never said it wouldn’t be happening. Just an important hurdle to cross before we start. I don’t know why you continually want to pick a fight. For the avoidance of doubt.

1. I am invested a lot by my standards but not enough that I can’t afford to lose

2. I believe the platform works

3. I do have concerns about efficacy of AVA6000 but do believe there will be cancer types it will be brought to market to treat

4. In any case 2nd and 3rd generations will overcome AVA6000 weaknesses

5.I don’t expect Avacta to make me a millionaire anytime soon if at all.

Icecool

. . . bit ahead of yourself to talk about P2 when we haven’t even been given results for P1a let alone started dosing in P1b.

Icecool

You are like a one track record. I’m not attacking Avacta I’m just giving my view on what it will take to move the SP and echoing the timeframe indicated by CC.

This helps to explain to some extent our cautious attitude towards this stock. There is no such thing as a dead cert until it crosses the line.

BenH

I suspect that was from a long time ago. I no longer expect a T/O. I think CC wants to “save the world “ rather than make a lot of money. So my money is on a JV with Novartis for AVA6000 leaving us to concentrate on pipeline development.

Yuyus

You’ve lost me

We’re obviously expecting loads of dosh soon if we can afford to p*ss it away on a rebranding exercise.